Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Amazon.com Inc (AMZN) said earlier this week that it had acquired healthcare start-up firm Health Navigator, or its second acquisition in the sector of healthcare services.

However, the financial terms of the agreement remained undisclosed.

Amazon shares closed higher for the seventh time in the past eleven trading sessions on NASDAQ on Thursday. The stock went up 1.06% ($18.61) to $1,780.78, after touching an intraday high at $1,787.97, or a price level not seen since October 22nd ($1,789.78).

Shares of Amazon.com Inc have risen 18.56% so far in 2019 compared with a 20.08% gain for the benchmark index, S&P 500 (SPX).

In 2018, Amazon’s stock went up 28.43%, thus, it outperformed the S&P 500, which registered a 6.24% loss.

According to the e-commerce giant, the acquisition of Health Navigator is a part of a new offering to its employees, Amazon Care. The latter is to ensure that Amazon employees receive fast-paced access to healthcare facilities without the need to make an appointment.

Last year, Amazon.com Inc bought online pharmacy PillPack.

Analyst stock price forecast and recommendation

According to CNN Money, the 43 analysts, offering 12-month forecasts regarding Amazon.com Inc’s stock price, have a median target of $2,275.00, with a high estimate of $2,615.00 and a low estimate of $2,080.00. The median estimate represents a 27.75% upside compared to the closing price of $1,780.78 on October 24th.

The same media also reported that at least 44 out of 48 surveyed investment analysts had rated Amazon.com Inc’s stock as “Buy”, while 4 – as “Outperform”.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Gold futures head for first weekly gain in four as Fed delays hikeGold futures head for first weekly gain in four as Fed delays hike Gold hovered near the highest level in two weeks on Friday and was on track to end three straight weekly declines after the Federal Reserve delayed an anticipated rate hike for what it seems later this year.Gold futures for delivery in […]
  • Outlook for USD/JPY cross during the upcoming weekOutlook for USD/JPY cross during the upcoming week US dollar concluded the week ending on October 13th on higher levels against the Japanese yen amid prospects of an approaching aggrement on the US budget impasse before the deadline date, on which, according to the US Treasury, the nation will […]
  • Forex Market: GBP/CAD daily forecastForex Market: GBP/CAD daily forecast During Friday’s trading session GBP/CAD traded within the range of 1.8216-1.8289 and closed at 1.8280.At 7:03 GMT today GBP/CAD was losing 0.02% for the day to trade at 1.8278. The pair touched a daily low at 1.8267 at 6:45 […]
  • EUR/NOK edges lower ahead of ECB rate decisionEUR/NOK edges lower ahead of ECB rate decision The EUR/NOK currency pair was a notch weaker on Thursday following Norway's manufacturing data and ahead of the outcome of the ECB’s March policy meeting.Norwegian manufacturing production stalled in January compared to a month […]
  • NZD/USD on seven-day lows on disappointing NZ manufacturing data, Fed minutesNZD/USD on seven-day lows on disappointing NZ manufacturing data, Fed minutes New Zealand dollar fell to its lowest point during the past seven trading sessions against its US counterpart on Thursday, after a report showed that manufacturing activity in New Zealand slowed down in September.NZD/USD fell to a session […]
  • Johnson & Johnson announces “exceptional” growth in pharmaceuticals businessJohnson & Johnson announces “exceptional” growth in pharmaceuticals business Johnson & Johnson announced “exceptional” growth in its pharmaceuticals business thanks to the rewards from a series of successful drug launches. Prescription medicines has proved itself to be the strongest part of the companys portfolio […]